| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |